COVISHIELD

Australian PM Scott Morrison released a statement on 1 October, recognising India's Covishield Vaccine. It has put India's Serum Institute manufactured Covid-19 vaccine under its list of 'recognised vaccines'. Yet, it is still unclear if this decision will at all help the Indian tourists and students as they're still asked to present vaccination certificates by the Australian authorities. Unvaccinated travellers will be asked to quarantine at… read-more

Kishore Khet Kumar was arrested by the Navi Mumbai police for the supposed black marketing of the Covishield vaccine. Reportedly, the man sold each dose of the vaccine at Rs 4,000 each. The police thereafter informed Food and Drug Administration officials who sent a decoy customer to entrap the accused. Besides, the police seized two vials and 15 doses of Covishield. Fraud and cheating charges were booked against the accused.

ICMR has revealed that the mixing of two different vaccines based on the ''adenovirus vector'' does not produce any adverse effects. Furthermore, the research revealed that mixing helps to fight the COVID-19 virus and also produces immunity better than excepted. The research in India also helps to mitigate the rumors about the adverse effects of vaccines. Reportedly, many countries have proven this process to be promising.

Serum Institute of India's Covishield vaccine is cleared for a travel pass in eight EU nations- Austria, Germany, Slovenia, Greece, Estonia, Iceland, Ireland, Spain, and Switzerland. Amidst issues of Covishield's travel pass clearance, Adar Poonawalla, CEO of Serum Institute tweeted on June 28, "I have taken this up at the highest levels and hope to resolve this matter soon." In the past, EMA had cleared only four vaccines. 

The vaccination doses ascribed for July may fail to meet the daily assigned vaccination targets. An affidavit issued by the Government mentioned that the states and union territories will be allotted 12 crore vaccine doses in July (40 lakh doses per day), which is lower than the target of one crore doses. These include ten crore doses of Covishield from Serum Institute of India and two crore doses of Covaxin from Bharat Biotech.